查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
妊娠纹治疗市场：按疗法、最终用户、地区规模、份额、展望、机会分析，2022-2028 年
市场调查报告书
商品编码
1213837

妊娠纹治疗市场：按疗法、最终用户、地区规模、份额、展望、机会分析，2022-2028 年

Stretch Marks Treatment Market, By Treatment, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

妊娠纹是皮肤快速拉伸或收缩时出现的一种痕迹。 妊娠纹可能出现在身体的不同部位，例如腹部、胸部、下背部和臀部。 这在怀孕期间、怀孕后和体重快速增加期间很常见。 妊娠纹无痛无害，但有些人担心自己皮肤的外观。 因此，全球对安全有效治疗的需求不断增长。

市场动态

全球肥胖负担的增加、怀孕人数的增加、对安全有效治疗的需求不断增长、意识的提高以及对家庭局部治疗的日益偏爱正在推动全球妊娠纹治疗市场的增长。这是预期的主要因素来推动增长。

例如，2022 年 4 月，Skin Science Solutions 推出了新一代设备 icoone roboderm，它利用专有的细胞技术提供无痛、无创的面部和身体年轻化。。 icoone 技术为面部和身体提供广泛的可定制和有效的治疗，包括妊娠纹和减少皱纹。

2021 年 1 月，Dermaclara 推出了新的和改进的 Enhanced Silicone Fusion 妊娠纹贴片和套件。 由于尺寸、粘度、可重复使用性和透气性方面的改进，新套件和贴片的整体效果比原始设计高 40%。

这项研究的主要特点

  • 本报告对全球妊娠纹治疗市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR%) 增长情况。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 它根据以下参数介绍了全球妊娠纹治疗市场的主要参与者，包括公司亮点、产品组合、主要亮点、绩效和策略。
  • 本研究涵盖的主要公司包括 Weleda、Union Swiss (Pty) Ltd.、Laboratoires Expanscience、HRA Pharma、Helix BioMedix Inc.、Dermaclara、Candela Corporation、Clarins Group、Basq Skin Care、Alliance Pharma PLC 和E.T. Browne Drug Co. Inc.（Palmers）等。
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 《全球妊娠纹治疗市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球妊娠纹治疗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按疗法分类
    • 市场概况：按最终用户分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 肥胖增加和怀孕增加
    • 激光和微晶换肤术的治疗费用飙升
    • 对安全有效的妊娠纹治疗的需求不断增长
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/批准
  • 害虫分析
  • 对 PORTER 的分析
  • 併购方案

第 4 章妊娠纹治疗的全球市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学
  • 供应方和需求方分析
  • 经济影响

第 5 章全球妊娠纹治疗市场：按治疗方式，2017-2028

  • 热门产品
  • 激光
  • 其他治疗

第 6 章全球妊娠纹治疗市场：按最终用户分类，2017-2028

  • 医院和诊所
  • 家用

第 7 章。全球妊娠纹治疗市场：按地区划分，2017-2028

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地方

第八章竞争格局

  • Weleda
  • Union Swiss（Pty）Ltd.
  • Laboratoires Expanscience
  • HRA Pharma
  • Helix BioMedix Inc.
  • Dermaclara
  • Candela Corporation
  • Clarins Group
  • Basq Skin Care
  • Alliance Pharma PLC
  • E. T. Browne Drug Co. Inc.（Palmers）

第 9 章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5466

Stretch mark is a kind of mark that occurs when the skin stretches or shrinks swiftly. Stretch marks commonly appear on the abdomen, breasts, hips, buttocks, or other parts of the body. Stretch marks often appear during or after pregnancy and after a sudden weight gain. Stretch marks aren't painful or harmful, but some people don't like the way they make their skin look. Thus, there is an increase in demand for safe and effective treatment worldwide.

Market Dynamics:

Growing burden of obesity across the world, increasing number of pregnancies, rise in demand for safe and effective treatment, rise in awareness, and rising preference for at-home topical treatments are major factors expected to drive growth of the global stretch marks treatment market.

For instance, in April 2022, Skin Science Solutions launched icoone roboderm, a new generation device that utilizes unique cellular technologies to offer painless and non-invasive facial and body rejuvenation. The icoone technology offers a wide range of customizable and effective treatments for both the face and body, including stretch marks and wrinkle reduction.

In January 2021, Dermaclara launched of newly improved Enhanced Silicone Fusion stretch mark patches and kit. With improvements to size, viscosity, reusability, and breathability, the new kit or patches have an overall increased effectiveness of 40% from its original design.

Key features of the study:

  • This report provides in-depth analysis of the global stretch marks treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global stretch marks treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Weleda, Union Swiss (Pty) Ltd., Laboratoires Expanscience, HRA Pharma, Helix BioMedix Inc., Dermaclara, Candela Corporation, Clarins Group, Basq Skin Care, Alliance Pharma PLC, and E. T. Browne Drug Co. Inc. (Palmers), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global stretch marks treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stretch marks treatment market.

Detailed Segmentation:

  • Global Stretch Marks Treatment Market, By Treatment:
    • Topical Product
    • Laser
    • Other Treatments
  • Global Stretch Marks Treatment Market, By End User:
    • Hospitals and Clinics
    • Home Use
  • Global Stretch Marks Treatment Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Weleda
    • Union Swiss (Pty) Ltd.
    • Laboratoires Expanscience
    • HRA Pharma
    • Helix BioMedix Inc.
    • Dermaclara
    • Candela Corporation
    • Clarins Group
    • Basq Skin Care
    • Alliance Pharma PLC
    • E.T. Browne Drug Co. Inc. (Palmers)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Treatment
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing burden of obesity and increasing number of pregnancies
    • High cost of laser and microdermabrasion treatment
    • Increase in demand for safe and effective stretch marks treatment
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Stretch Marks Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Stretch Marks Treatment Market, By Treatment, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Topical Product
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Laser
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Treatments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Stretch Marks Treatment Market, By End User, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Home Use
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Stretch Marks Treatment Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Weleda
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Union Swiss (Pty) Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratoires Expanscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HRA Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Helix BioMedix Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dermaclara
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Candela Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clarins Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Basq Skin Care
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alliance Pharma PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • E. T. Browne Drug Co. Inc. (Palmers)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us